A rational approach to antioxidant therapy and vitamin E

Alternative Therapies in Health and Medicine

Volumn 11, Issue 1, 2005, Pages 14-17

  Hyman, Mark ^b   Pizzorno, Joseph ^b   Weil, Andrew ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE;

ARTERIOSCLEROSIS; CLINICAL TRIAL; COLON CANCER; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DIET; DRUG INHIBITION; DRUG SAFETY; FIBROCYSTIC BREAST DISEASE; GENE EXPRESSION; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; LIFESTYLE; META ANALYSIS; NOTE; OSTEOARTHRITIS; PREMENSTRUAL SYNDROME; PROSTATE CANCER; RETINA MACULA DEGENERATION; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDATION; META-ANALYSIS; OXIDATIVE STRESS; RESEARCH DESIGN; TREATMENT OUTCOME; UNITED STATES; VITAMIN E;

EID: 12344303272     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (36)

1. Miller ER III, Pastor-Barriuso R, Dalal D, et al. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann Intern Med. 2004 Nov 10
2. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-333.
3. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148:S19-S26.
4. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001 Aug 22-29;286(8):954-959. Review.
5. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337(8):536-542.
6. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of Data in Abstracts of Published Research Articles. JAMA. 1999; 281: 1110-1111
7. Williams R. Biochemical individuality. New York: John Wiley and Sons, 1963.
8. Neuzil J, Weber C, Kontush A. The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis. 2001;157:257-283.
9. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1986;347:781-786.
10. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo controlled trial. Lancet. 2000;356:1213-1218.
11. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360: 23-33.
12. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
13. Mitchinson MJ, Stephens NG, Parsons A, et al. Mortality in the CHAOS trial. Lancet. 1999 Jan 30;353(9150):381-382.
14. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
15. Bressler NM, Bressler SB, Congdon NG, et al. Age-Related Eye Disease Study Research Group. Potential public health impact of Age-Related Eye Disease Study results:AREDS report no. 11. Arch Opthalmol. 2003;121(11):1621-1624.
16. Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002;288:2432-2440.
17. Waters D. Vitamins and Hormone Therapy for CAD. JAMA. 2003;289:982.
18. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993 May 20;328(20):1444-1449.
19. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993 May 20;328(20):1450-1456.
20. Salonen RM, Nyyssonen K, Kaikkonen J, et al. Antioxidant Supplementation in Atherosclerosis Prevention Study.Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003 Feb 25;107(7):947-953.
21. Brigelius-Flohe R, Kelly FJ, Salonen JT, et al. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002 Oct; 76(4):703-716.
22. Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004;19(4):380-389.
23. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164(14):1552-1556.
24. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017-2023.
25. Munteanu A, Zingg JM, Azzi A. Anti-atherosclerotic effects of vitamin E-myth or reality? J Cell Mol Med. 2004;8(1):59-76.
26. Manzella D, Barbieri M, Ragno E, Paolisso G. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr. 2001 Jun;73(6):1052-1057.
27. Virtamo J, Pietinen P, Huttunen JK, et al. ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003 Jul 23;290(4):476-485.
28. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002. 30;359(9312):1108-1113.
29. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336:1216-1222.
30. http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0266. shtml
31. http://www.iom.edu/project.asp?id=4574
32. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Jul 1;139(1):56-70. Review.
33. The Lewin Group. A Study of the Cost Effects of Daily Multivitamins for Older Adults. Prepared for Wyeth Consumer Healthcare, January 14, 2004.
34. Fairfield KM, Fletcher RH. Vitamins for Chronic Disease Prevention in Adults: Scientific Review JAMA, Jun 2002;287:3116-3126.
35. Willett WC, Stampfer MJ. What Vitamins Should I be Taking Doctor? N Engl J Med. 2001;345:1819-1824.
36. Moynihan, R, Bero, L, Ross-Degnan, D. Coverage by news media of the benefits and risks of medications. N Engl J Med. 2000 Jun 1;342(22):1645-50.